陶寡合物通过细胞的蛋白质损害记忆和突触可塑性
Claudia Balducci1, Franca Orsini1, Milica Cerovic1
1Department of Neuroscience, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Via Mario Negri 2, 20156, Milan, Italy.
Acta neuropathologica communications
|January 28, 2025
概括
细胞蛋白 (PrPC) 在阿尔茨海默病模型中调解寡合体 (TauOs) 的毒性作用. 阻止这种相互作用可能为病症提供一种新的治疗策略.
科学领域:
- 神经科学是一个神经科学.
- 分子生物学分子生物学
- 生物化学 生物化学
背景情况:
- 异常化陶聚合物,特别是陶寡合物 (TauOs),是神经元功能障碍和阿尔茨海默病 (AD) 和其他陶病的死亡的核心.
- 陶对神经毒性的确切机制尚不清楚,尽管细胞蛋白 (PrPC) 被认为是潜在的调解者.
研究的目的:
- 调查PrPC是否调解TauOs对记忆和突触可塑性的有害影响.
- 为了确定TaoOs和PrPC之间是否存在直接相互作用.
主要方法:
- 在野生型 (WT) 和PrPC淘汰赛 (Prnp0/0) 小鼠中对识别记忆和长期增强TAUO效应的比较.
- 表面等离子体共振来评估TauO-PrPC的结合亲和力.
- 免疫光分析以评估TauO与PrPC表达细胞的关联.
主要成果:
- 在WT小鼠中,TauOs损害了识别记忆和长期强化,但在Prnp小鼠中没有.
- 在TauOs和PrPC之间观察到高亲和度结合 (KD为20-50nM).
- TauOs显示了PrPC与细胞的剂量依赖性关联以及与PrPC的同定位.
结论:
- 通过直接相互作用,PrPC调解了TauOs的神经毒性作用.
- 针对PrPC-TauO相互作用代表了AD和陶病的潜在治疗策略.
相关概念视频
Amyloid Fibrils
9.2K
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
9.2K
Role of Neurotransmitters in Memory
404
Neurotransmitters are integral to the brain's communication system, enabling neurons to transmit signals across synapses. This chemical exchange underpins various cognitive functions, including memory processes. The role of neurotransmitters in memory is multifaceted, influencing the encoding, consolidation, and retrieval of memories through their action on different neural circuits.
Glutamate and Synaptic Plasticity
Glutamate, the brain's main excitatory neurotransmitter, is...
Glutamate and Synaptic Plasticity
Glutamate, the brain's main excitatory neurotransmitter, is...
404
Long-term Depression
2.5K
Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
Calcium Ion Concentration Mechanism
If over...
Calcium Ion Concentration Mechanism
If over...
2.5K
Long-term Potentiation
2.7K
Long-term potentiation, or LTP, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTP is the process of synaptic strengthening that occurs over time between pre and postsynaptic neuronal connections. The synaptic strengthening of LTP works in opposition to the synaptic weakening of long-term depression (LTD) and together are the main mechanisms that underlie learning and memory.
Hebbian LTP
LTP can occur when...
Hebbian LTP
LTP can occur when...
2.7K
Alzheimer's Disease: Overview
439
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
439


